Nancy Stuart Net Worth & Insider Trades
Nancy Stuart - Chief Operating Officer, Concert Pharmaceuticals, Inc
What is Nancy Stuart's Net Worth?
The current estimated net worth of Concert Pharmaceuticals, Inc's Chief Operating Officer, Nancy Stuart, is estimated to be about $3.42M . Nancy Stuart owns about 262,596 units of Concert Pharmaceuticals, Inc common stock. In the last 9 years at Concert Pharmaceuticals, Inc, Nancy Stuart has sold an estimated value of $2.84M worth.
What is Nancy Stuart's Past Insider Trading?
Nancy Stuart's largest purchase order was 21,238 units , worth over $80.49K on June 24, 2020. Nancy Stuart's largest sale order was 46,430 units , worth over $696.45K on March 12, 2015. In total, Nancy Stuart has made about 32 transactions over 9 years of their time at Concert Pharmaceuticals, Inc. Nancy Stuart usually trades in January, with the busiest year in 2018. The most recent transaction was a sale order of 6,048 units , worth over $50.38K on February 16, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nancy Stuart
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What was Nancy Stuart's Salary in 2020?
As Chief Operating Officer of Concert Pharmaceuticals, Inc, Nancy Stuart has a total base salary of $444,530 . Nancy Stuart received compensation valued at about $1,582,764 in 2020 after becoming Chief Operating Officer. The vast majority of their compensation came in the form of option awards of $455,212 , stock awards of $493,096 , other earnings, plans or compensations of $177,812 , and other compensation of $12,114 .
What is Nancy Stuart's' Mailing Address?
- Mailing address is 99 Hayden Avenue, Suite 500 Lexington MA 02421 MA
Concert Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
Roger D. Tung | 2020 | $581,967 | - | $1,011,657 | $1,098,957 | $320,082 | $12,114 | $3,024,777 |
Roger D. Tung | 2019 | $562,287 | - | $1,889,500 | - | $309,258 | $11,304 | $2,772,349 |
James V. Cassella | 2020 | $450,633 | - | $283,144 | $306,708 | $225,317 | $15,408 | $1,281,210 |
James V. Cassella | 2019 | $435,394 | - | $708,563 | $319,397 | $217,697 | $13,988 | $1,695,039 |
Nancy Stuart | 2020 | $444,530 | - | $455,212 | $493,096 | $177,812 | $12,114 | $1,582,764 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1367920/000136792021000022/a2021proxy.htm
What are Concert Pharmaceuticals, Inc's Past Insider Trades?
Concert Pharmaceuticals, Inc's most recent insider trade came on February 16, 2023 by Nancy Stuart who sold 6,048 units worth $50.38K . In the last 9 years, insiders at Concert Pharmaceuticals, Inc have sold an estimated value of $72.41M and bought an estimated value of $26.82M worth of shares. Insider trading is most common in June, with the busiest year in 2018 and 2015. The most active traders at the company are Nancy Stuart, Chief Operating Officer, Roger Tung, Chief Executive Officer, and James Cassella V, Chief Development Officer .
CONCERT PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |